Insider Buying: Indivior PLC (LON:INDV) Insider Acquires 2,650 Shares of Stock

Indivior PLC (LON:INDVGet Free Report) insider Graham Hetherington bought 2,650 shares of the business’s stock in a transaction that occurred on Monday, November 20th. The stock was purchased at an average price of GBX 1,350 ($16.89) per share, for a total transaction of £35,775 ($44,757.91).

Indivior Stock Down 0.1 %

LON:INDV traded down GBX 1.81 ($0.02) during trading hours on Tuesday, hitting GBX 1,348.19 ($16.87). 166,462 shares of the company traded hands, compared to its average volume of 374,397. The company has a quick ratio of 1.52, a current ratio of 0.99 and a debt-to-equity ratio of 240.17. The firm’s 50-day simple moving average is GBX 1,608.49 and its 200-day simple moving average is GBX 1,682.37. Indivior PLC has a one year low of GBX 1,241 ($15.53) and a one year high of GBX 2,020 ($25.27). The company has a market cap of £1.86 billion, a PE ratio of -978.26, a PEG ratio of -5.57 and a beta of 0.06.

Analysts Set New Price Targets

Separately, Morgan Stanley raised their price objective on Indivior from GBX 2,500 ($31.28) to GBX 2,700 ($33.78) in a research note on Thursday, August 3rd.

Check Out Our Latest Analysis on Indivior

About Indivior

(Get Free Report)

Indivior PLC, together with its subsidiaries, engages in the development, manufacture, and sale of buprenorphine-based prescription drugs for the treatment of opioid dependence and co-occurring disorders. The company's product pipeline focuses on treating opioid use disorder, addiction, and schizophrenia.

Featured Stories

Receive News & Ratings for Indivior Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Indivior and related companies with's FREE daily email newsletter.